Home › Cutaneous T-Cell Lymphoma › Massachusetts › Boston
Cutaneous T-Cell Lymphoma clinical trials in Boston, MA
5 studies for Cutaneous T-Cell Lymphoma are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
RecruitingPhase 1
- Beth Israel Deaconess Medical Center - Research, Boston
A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL
RecruitingPhase 2
- Dana-Farber Cancer Institute, Boston
A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma
Recruiting
- Dana Farber Cancer Institute, Boston
Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma
RecruitingPhase 2
- Dana Farber Cancer Institute, Boston
A Registry for People With T-cell Lymphoma
RecruitingObservational study
- Massachusetts General Hospital (Data Collection Only), Boston
- Dana Farber Cancer Institute (Data Collection Only), Boston
Cutaneous T-Cell Lymphoma trials in other cities
- New York City, NY9 studies
- Baldwin Park, CA8 studies
- Houston, TX5 studies
- New Haven, CT4 studies
- Ann Arbor, MI3 studies
- Chicago, IL3 studies
- Scottsdale, AZ3 studies
- Durham, NC3 studies
- Tampa, FL3 studies
- Columbus, OH3 studies
- Rochester, MN3 studies
Other studies in Boston
- Breast Cancer111 studies
- Non-Small Cell Lung Cancer90 studies
- Cancer (all types)86 studies
- Colorectal Cancer63 studies
- Metastatic Cancer63 studies
- Lung Cancer62 studies
- Ovarian Cancer61 studies
- Prostate Cancer59 studies
- Depression52 studies
- Endometrial Cancer50 studies
- Heart Failure44 studies
- Acute Myeloid Leukemia44 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.